Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Futura Medical plc (FUM) Ordinary GBP0.02

Sell:33.00p Buy:35.00p 0 Change: 0.90p (2.58%)
Market closed Prices as at close on 18 November 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:33.00p
Buy:35.00p
Change: 0.90p (2.58%)
Market closed Prices as at close on 18 November 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:33.00p
Buy:35.00p
Change: 0.90p (2.58%)
Market closed Prices as at close on 18 November 2019 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Futura Medical plc is a United Kingdom-based pharmaceutical company that develops products for consumer healthcare. The Company is engaged in the research and development of pharmaceutical drugs and medical devices and the commercial exploitation. It is also engaged in transdermal delivery and has developed a transdermal technology, DermaSys for the absorption of active molecules through the skin. It specializes in sexual health and pain relief, and has approximately five products in its development pipeline, which include CSD500, MED2002, TPR100, TIB200 and SPR300. Its CSD500 product incorporates an erectogenic gel (known as Zanifil gel) to help men maintain a firmer erection during intercourse whilst wearing a condom. Its MED2002 is a gel applied directly to the penis for the treatment of male erectile dysfunction (ED). The Company's TPR100 is a gel to provide pain relief. Its SPR300 is a gel, which combines methyl salicylate and menthol with the DermaSys delivery system.

Contact details

Address:
Unit 40
Surrey Technology Centre, Occam Road
GUILDFORD
GU2 7YG
United Kingdom
Telephone:
+44 (01483) 685670
Website:
www.futuramedical.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 11 September 2019 11/09/19
AGM 24 June 2019 24/06/19
Final results 10 April 2019 10/04/19

General stock information

EPIC:
FUM
ISIN:
GB0033278473
Market cap:
£69.58 million
Shares in issue:
204.66 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • James Barder
    Chief Executive Officer, Executive Director
  • Ken James
    Executive Director, Head of R&D

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.